Jabra Enhance Select M3 Review (2026): A Big Price for Small Wins

The latest Jabra hearing aids offer marginal improvements for a premium price, signaling continued incremental innovation in the OTC market.

Jabra has released its new M-series line of over-the-counter hearing aids, including the Enhance Select M3, M2, and M1. The M3, priced at $1,995, features incremental upgrades over previous models, such as an improved autofocus for speech in noisy environments and an adaptive listening mode. Despite these enhancements, the core functionality and design remain largely unchanged from prior generations. The device offers clear audio in quiet settings and a 24-hour battery life, but Bluetooth streaming quality is still considered subpar, and the charging case is noted as bulky. Jabra continues to provide three years of access to audiologist support and a robust self-testing app.

The direct-to-consumer hearing aid market continues to see incremental, rather than groundbreaking, advancements. While Jabra's new M3 offers refined features like enhanced autofocus and adaptive listening, these improvements are only moderately effective and do not fundamentally alter the user experience from previous models. This suggests that manufacturers are focusing on subtle refinements to existing technology rather than pursuing disruptive innovations, potentially a strategy to balance development costs with consumer expectations for noticeable upgrades.

The pricing strategy of high-end OTC hearing aids remains a key point of discussion, with the M3 entering the market at a substantial $1,995. This price point, while offering some advanced features, positions Jabra's top model as a significant investment, especially when compared to its less expensive siblings, the M2 and M1, which offer comparable performance for many users. The market appears to be segmenting, with premium OTC devices aiming to approach prescription-grade quality, but the high cost may limit accessibility for a broad consumer base.